COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab

Nefrologia (Engl Ed). 2021 May-Jun;41(3):354-356. doi: 10.1016/j.nefro.2020.07.001. Epub 2020 Jul 27.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Allergic Agents / therapeutic use*
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / complications*
  • COVID-19 / diagnosis*
  • COVID-19 Nucleic Acid Testing
  • Chronic Urticaria / drug therapy*
  • Female
  • Glomerulonephritis, Membranoproliferative / complications
  • Glucocorticoids / therapeutic use
  • Humans
  • Middle Aged
  • Omalizumab / therapeutic use*
  • Prednisone / therapeutic use
  • Renal Dialysis*
  • Renal Insufficiency, Chronic / etiology
  • Renal Insufficiency, Chronic / therapy*
  • Syndrome

Substances

  • Anti-Allergic Agents
  • Glucocorticoids
  • Omalizumab
  • Prednisone